Page last updated: 2024-10-18

dihydroxyphenylalanine and Hypertension, Malignant

dihydroxyphenylalanine has been researched along with Hypertension, Malignant in 3 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ARNOLD, OH1
CANNON, PJ1
WHITLOCK, RT1
MORRIS, RC1
ANGERS, M1
LARAGH, JH1
Bock, KD1

Other Studies

3 other studies available for dihydroxyphenylalanine and Hypertension, Malignant

ArticleYear
[The therapy fo malignant hypertension].
    Deutsches medizinisches Journal, 1962, Aug-20, Volume: 13

    Topics: Dihydroxyphenylalanine; Hypertension; Hypertension, Malignant

1962
Effect of alpha-methyl DOPA in severe and malignant hypertension.
    JAMA, 1962, Mar-03, Volume: 179

    Topics: Dihydroxyphenylalanine; Hypertension; Hypertension, Malignant; Methyldopa

1962
[Conservative treatment of hypertension].
    Munchener medizinische Wochenschrift (1950), 1970, Nov-20, Volume: 112, Issue:47

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aniline Compounds; Dihydroxyphenylalanine; Female; Guaneth

1970